CIK 0001055726
- Non-accelerated filer
- Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330969592
- Phone
- +1 858-410-3134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-03-09 | Kim Jong Joseph Chief Executive Officer | Shares withheld for taxes | −15,944 | $4.51 | $72K | 2,216,211 |
| 2018-03-09 | Kim Jong Joseph Chief Executive Officer | Exercise or conversion · Restricted Stock Unit | −57,334 | 57,333 | ||
| 2018-03-09 | Weiner David B. Director | Exercise or conversion | +10,000 | 750,956 | ||
| 2018-03-09 | Weiner David B. Director | Exercise or conversion | +5,333 | 756,289 | ||
| 2018-03-09 | Weiner David B. Director | Exercise or conversion · Restricted Stock Unit | −10,000 | 10,000 | ||
| 2018-03-09 | Weiner David B. Director | Exercise or conversion · Restricted Stock Unit | −5,333 | 5,333 | ||
| 2018-03-05 | Weiner David B. Director | Grant or award · Common Stock Option | +60,000 | 60,000 | ||
| 2018-03-05 | Weiner David B. Director | Grant or award · Restricted Stock Unit | +35,000 | 35,000 | ||
| 2018-03-05 | Bagarazzi Mark Chief Medical Officer | Exercise or conversion | +8,333 | 51,443 | ||
| 2018-03-05 | Bagarazzi Mark Chief Medical Officer | Shares withheld for taxes | −2,815 | $4.29 | $12K | 48,628 |
| 2018-03-05 | Bagarazzi Mark Chief Medical Officer | Exercise or conversion · Restricted Stock Unit | −8,333 | 0 | ||
| 2018-03-05 | Bagarazzi Mark Chief Medical Officer | Grant or award · Common Stock Option | +126,500 | 126,500 | ||
| 2018-03-05 | Bagarazzi Mark Chief Medical Officer | Grant or award · Restricted Stock Unit | +82,700 | 82,700 | ||
| 2018-03-05 | KIES PETER CFO | Exercise or conversion | +8,333 | 55,381 | ||
| 2018-03-05 | KIES PETER CFO | Shares withheld for taxes | −3,407 | $4.29 | $15K | 51,974 |
| 2018-03-05 | KIES PETER CFO | Exercise or conversion · Restricted Stock Unit | −8,333 | 0 | ||
| 2018-03-05 | KIES PETER CFO | Grant or award · Common Stock Option | +126,500 | 126,500 | ||
| 2018-03-05 | KIES PETER CFO | Grant or award · Restricted Stock Unit | +82,700 | 82,700 | ||
| 2018-03-05 | Sardesai Niranjan Chief Operating Officer | Exercise or conversion | +8,333 | 93,416 | ||
| 2018-03-05 | Sardesai Niranjan Chief Operating Officer | Shares withheld for taxes | −2,815 | $4.29 | $12K | 90,601 |
Page 42 of 49 · 961 trades